Advancing Patented Cannabinoid Science Into Drug Development
GreenWay Herbal Products, LLC is a research-driven company focused on the discovery, patenting, and development of novel cannabinoid compositions intended for evaluation as regulated pharmaceutical candidates.
GreenWay Herbal Products, LLC is a research-driven company focused on the discovery, patenting, and development of novel cannabinoid compositions with therapeutic potential.
Our work bridges academic research, intellectual property, and translational drug development.
Intellectual Property
Issued U.S. and international patents covering novel cannabinoid compositions and methods of use.
Research Origin
Developed through university-led research collaborations and peer-reviewed scientific research.
Drug Development Focus
Advancing cannabinoid science toward regulated pharmaceutical pathways and clinical applications.
Patent-Backed Cannabinoid Innovation
GreenWay Herbal Products holds issued intellectual property covering a novel equal-molar composition of cannabidiol (CBD) and cannabidiolic acid (CBDA).
This work originated from academic research exploring cannabinoid interactions relevant to inflammatory and immune-mediated disease mechanisms.
Our focus is the continued development of cannabinoid-derived pharmaceutical candidates through disciplined scientific and regulatory pathways.
Focused on Translational Drug Development
GreenWay Herbal Products is actively pursuing the advancement of its cannabinoid intellectual property toward pharmaceutical development.
This includes continued research, formulation development, regulatory planning, and evaluation of clinical pathways appropriate for cannabinoid-based drug candidates.
Composition-of-matter and method-of-use IP
Preclinical research and pharmacological evaluation
Regulatory strategy and pathway assessment
Strategic licensing and development partnerships
GreenWay Herbal Products, LLC is not a consumer wellness brand and does not market dietary supplements as its core business.